Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4287125
Max Phase: Preclinical
Molecular Formula: C42H45F6N3O5
Molecular Weight: 785.83
Molecule Type: Small molecule
Associated Items:
ID: ALA4287125
Max Phase: Preclinical
Molecular Formula: C42H45F6N3O5
Molecular Weight: 785.83
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(C)C
Standard InChI: InChI=1S/C42H45F6N3O5/c1-25(2)37(51-39(54)30-20-31(41(43,44)45)22-32(21-30)42(46,47)48)40(55)49-33(18-28-14-7-5-8-15-28)23-35(52)34(19-29-16-9-6-10-17-29)50-36(53)24-56-38-26(3)12-11-13-27(38)4/h5-17,20-22,25,33-35,37,52H,18-19,23-24H2,1-4H3,(H,49,55)(H,50,53)(H,51,54)/t33-,34-,35-,37-/m0/s1
Standard InChI Key: OGXSZVBVQHONIQ-SZHYKVQFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 785.83 | Molecular Weight (Monoisotopic): 785.3263 | AlogP: 7.38 | #Rotatable Bonds: 16 |
Polar Surface Area: 116.76 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.26 | CX Basic pKa: | CX LogP: 8.30 | CX LogD: 8.30 |
Aromatic Rings: 4 | Heavy Atoms: 56 | QED Weighted: 0.09 | Np Likeness Score: -0.35 |
1. Matralis AN, Xanthopoulos D, Huot G, Lopes-Paciencia S, Cole C, de Vries H, Ferbeyre G, Tsantrizos YS.. (2018) Molecular tools that block maturation of the nuclear lamin A and decelerate cancer cell migration., 26 (20): [PMID:30309670] [10.1016/j.bmc.2018.10.001] |
Source(1):